货号 | MAB25373-100 |
简介 | Recombinant Monoclonal Antibody |
别名 | FGF21; FGF-21; fibroblast growth factor 21 | 全称 | Fibroblast Growth Factor 21 |
应用 | Neutralization |
目标/特异性 | Detects human FGF-21 in direct ELISAs. |
使用方法 | Neutralization: Measured by its ability to neutralize FGF-21-induced proliferation in BaF3 mouse pro-B cell line transfected with human FGF-RIIIc. The Neutralization Dose (ND50) is typically 0.5-3 μg/mL in the presence of Recombinant Mouse Klotho beta. |
来源 | Recombinant Monoclonal Goat IgG2B Clone # 40020A |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 26291 (Human); 56636 (Mouse) |
纯化方式 | Protein A or G purified from cell culture supernatant |
免疫原 | E. coli-derived recombinant human FGF-21 His29-Ser209 Accession # Q9NSA1 |
内毒素水平 | <0.10 EU per 1 μg of the antibody by the LAL method. |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitue at 0.5mg/mL in sterile PBS. |
背景 | Fibroblast growth factor 21 (FGF-21) is a member of the FGF gene family, which currently contains 22 human members. Based on its structure, it is further classified as an FGF19 subfamily member. This subfamily includes FGF-19, -21, and -23. Like all other FGF subfamilies, FGF-19 subfamily members contain a 120 amino acid (aa) core FGF domain that exhibits a beta -trefoil structure (1, 2). Unlike other FGF subfamilies, FGF-19 subfamily members apparently exhibit poor binding to ECM, resulting in highly diffusible molecules (3). The c-DNA for FGF-21 predicts a 209 aa polypeptide that contains a 28 aa signal sequence and a 181 aa mature region (4). Notably, FGF-21, as well as FGF-19 show limited binding to heparin (4). One potential alternate splice form has been reported. It shows a 43 aa substitution for the |
运输条件 | Blue Ice |
存放说明 | -20℃ |
参考文献 |
|
Cell Proliferation Induced by FGF-21 and Neutralization by Human FGF-21 Antibody. In the presence of Recombinant Mouse Klotho beta (Catalog # 2619-KB), Recombinant Human FGF-21 (Catalog # 2539-FG) stimulates proliferation in the BaF3 mouse pro-B cell line transfected with human FGF-RIIIc in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Recombinant Human FGF-21 (500 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human FGF-21 Mononclonal Antibody (MAB25373). The ND50 is typically 0.5-3 μg/mL. |